This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Ashfaq Ahmad Parkar: Innovator in Pharmaceutical Sciences
Introduction
Ashfaq Ahmad Parkar is a prominent inventor based in Princeton, NJ, USA. He is recognized for his contributions to the field of pharmaceutical sciences, particularly in the development of innovative therapeutic compounds. With three patents to his name, Parkar's work has significantly advanced the understanding and treatment of various diseases.
Latest Patents
Among Ashfaq Ahmad Parkar's latest patents is an innovative work on Thienopyrazoles. This patent details compounds of formula I and their pharmaceutical applications, particularly highlighting their use in modulating disease states through the inhibition of protein kinases, specifically targeting interleukin-2 inducible tyrosine kinase (ITK). Additionally, he has developed nucleic acid molecules encoding prostaglandin receptor proteins, focusing on a novel member of the prostanoid receptor family—a guinea pig prostaglandin D2 receptor. This research leads to various potential applications in pharmacology.
Career Highlights
Parkar is currently affiliated with Aventis Pharmaceuticals Inc., where he continues to push the boundaries of pharmaceutical research and innovation. His work is aimed at addressing pressing health issues through the development of new therapeutic strategies and medications.
Collaborations
Throughout his career, Ashfaq Ahmad Parkar has collaborated with esteemed colleagues such as Paul R. August and Theresa Kuntzweiler. These partnerships have facilitated the exchange of ideas and enhance the collective impact of their research efforts in the pharmaceutical realm.
Conclusion
In summary, Ashfaq Ahmad Parkar stands out as a significant inventor in the pharmaceutical industry. His innovative patents, combined with his valuable collaborations, contribute to the ongoing advancements in the treatment of disease through novel therapeutic pathways. His work not only reflects his dedication to science but also holds promise for improving patient outcomes in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile